Aspirin might prevent Vioxx cardiac damage
13th Sep 2005, 16:52 GMT
Low-dose aspirin might prevent the cardiovascular damage known to arise from use of the painkiller rofecoxib (Vioxx.), suggest new findings from mouse studies by Duke University Medical Center researchers. Their findings that a chemical imbalance might underlie such damage could also lead to the development of anti-inflammatory drugs without the adverse side effects, the researchers said.
Latest news from EurekAlert! - Chemistry, Physics and Materials Sciences:
- Ludwig Fund donates $20 million to University of Chicago for cancer research
- Two PITT researchers make Scientific American 50 of Leaders in Science and Technology
- ICON issues Survey of Nanotechnology Practices
- Fatigue in women is reduced in stress-related cortisol study
- Scientists design simple dipstick test for cocaine, other drugs
- NYU researchers developing molecular delivery vehicles for genetic therapies
- Hebrew University in leading spots in world university rankings
- ALTRAN unveils its energy efficiency concepts solutions
- A medical micropump
- Cheaper color printing by harnessing Ben Franklin's electrostatic forces